These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7381731)

  • 1. Hypocholesterolemic agents VII: Inhibition of beta-hydroxy-beta-methylglutaryl-CoA reductase by monoesters of substituted glutaric acids.
    Boots MR; Yeh YM; Boots SG
    J Pharm Sci; 1980 May; 69(5):506-9. PubMed ID: 7381731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypocholesterolemic agents V: Inhibition of beta-hydroxy-beta-methylglutaryl coenzyme A reductase by substituted 4-biphenylylalkyl carboxylic acids and methyl esters.
    Boots SG; Boots MR; Guyer KE; Marecki PE
    J Pharm Sci; 1976 Sep; 65(9):1374-80. PubMed ID: 966157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypocholesterolemic agents IV: inhibition of beta-hydroxy-beta-methyglutaryl coenzyme A reductase by arylalkenyl and arylepoxy hydrogen succinates and glutarates.
    Boots MR; Marecki PE; Boots SG; Guyer KE
    J Pharm Sci; 1976 May; 65(5):724-7. PubMed ID: 932941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocholesterolemic agents III: inhibition of beta-hydroxy-beta-methylglutaryl coenzyme A reductase by half acid esters of 1-(4-biphenylyl)pentanol.
    Guyer KE; Boots SG; Marecki PE; Boots MR
    J Pharm Sci; 1976 Apr; 65(4):548-52. PubMed ID: 1271253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Alkyl-3-hydroxyglutaric acids: a new class of hypocholesterolemic HMG CoA reductase inhibitors. 1.
    Baran JS; Laos I; Langford DD; Miller JE; Jett C; Taite B; Rohrbacher E
    J Med Chem; 1985 May; 28(5):597-601. PubMed ID: 3989819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Endo A
    J Antibiot (Tokyo); 1980 Mar; 33(3):334-6. PubMed ID: 7380744
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparation of a soluble 58 kDa-3-hydroxy-3-methylglutaryl CoA reductase from liver microsomes and its inhibition by ethoxysilatrane, a hypocholesterolemic compound.
    Omkumar RV; Mehta PP; Kurup CK; Ramasarma T
    Mol Cell Biochem; 1992 Mar; 110(2):145-53. PubMed ID: 1584203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity.
    Endo A; Kuroda M; Tanzawa K
    FEBS Lett; 1976 Dec; 72(2):323-6. PubMed ID: 16386050
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of pravastatin on hepatic 3-hydroxy-3-methylglutaryl CoA reductase obtained from poloxamer 407-induced hyperlipidemic rats.
    Johnston TP; Palmer WK
    Pharmacotherapy; 1997; 17(2):342-7. PubMed ID: 9085326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypocholesterolemic agents. II. Inhibition of -hydroxy- -methylglutaryl coenzyme A reductase by arylalkyl hydrogen succinates and glutarates.
    Boots MR; Boots SG; Noble CM; Guyer KE
    J Pharm Sci; 1973 Jun; 62(6):952-7. PubMed ID: 4576426
    [No Abstract]   [Full Text] [Related]  

  • 11. Mevinolin: a highly specific inhibitor of microsomal 3-hydroxy-3-methylglutaryl-coenzyme A reductase of radish plants.
    Bach TJ; Lichtenthaler HK
    Z Naturforsch C Biosci; 1982; 37(1-2):46-50. PubMed ID: 6917646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 15-oxa-32-vinyl-lanost-8-ene-3 beta,32 diol on the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase and low density lipoprotein receptor in rat liver.
    Ness GC; Lopez D; Chambers CM; Zhao Z; Beach DL; Ko SS; Trzaskos JM
    Arch Biochem Biophys; 1998 Sep; 357(2):259-64. PubMed ID: 9735166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acyl-CoA inhibition of beta-hydroxy-beta-methylglutaryl-CoA reductase activity.
    Faas FH; Carter WJ; Wynn JO
    Biochim Biophys Acta; 1978 Nov; 531(2):158-66. PubMed ID: 718968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 9. The synthesis and biological evaluation of novel simvastatin analogs.
    Hartman GD; Halczenko W; Duggan ME; Imagire JS; Smith RL; Pitzenberger SM; Fitzpatrick SL; Alberts AW; Bostedor R; Chao YS
    J Med Chem; 1992 Oct; 35(21):3813-21. PubMed ID: 1433193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between tissue selectivity and lipophilicity for inhibitors of HMG-CoA reductase.
    Roth BD; Bocan TM; Blankley CJ; Chucholowski AW; Creger PL; Creswell MW; Ferguson E; Newton RS; O'Brien P; Picard JA
    J Med Chem; 1991 Jan; 34(1):463-6. PubMed ID: 1992149
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes.
    Yamamoto A; Hoshi K; Ichihara K
    Eur J Pharmacol; 1998 Nov; 361(1):143-9. PubMed ID: 9851551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cultured L cells by the hypocholesterolemic drug clofibrate.
    Kaneko I; Hazama-Shimada Y; Kuroda M; Endo A
    Biochem Biophys Res Commun; 1977 Jun; 76(4):1207-13. PubMed ID: 901472
    [No Abstract]   [Full Text] [Related]  

  • 18. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. 1976.
    Endo A; Kuroda M; Tanzawa K
    Atheroscler Suppl; 2004 Oct; 5(3):39-42. PubMed ID: 15531273
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis, biological profile, and quantitative structure-activity relationship of a series of novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Sit SY; Parker RA; Motoc I; Han W; Balasubramanian N; Catt JD; Brown PJ; Harte WE; Thompson MD; Wright JJ
    J Med Chem; 1990 Nov; 33(11):2982-99. PubMed ID: 2231596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver.
    Keller RK; Zhao Z; Chambers C; Ness GC
    Arch Biochem Biophys; 1996 Apr; 328(2):324-30. PubMed ID: 8645011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.